Management of common adverse effects of antipsychotic medications

Stroup, T. Scott, Gray, Neil·2018·World Psychiatry

Cited by (572)

Items 101–200 of 572

  1. Samidorphan/olanzapine combination therapy for schizophrenia: Efficacy, tolerance and adverse outcomes of regimen, evidence-based review of clinical trials
    Syeda Tayyaba Rehan, Abdul Hannan Siddiqui, Zayeema Khan, Laiba Imran, Abdul Ahad Syed, Muhammad Junaid Tahir, Zahra Jassani, Manjeet Singh, Muhammad Sohaib Asghar, Ali Ahmed · 2022 · Annals of Medicine and Surgery
  2. Genetic proxies for antihypertensive drugs and mental disorders: Mendelian randomization study in European and East Asian populations
    Bohan Fan, Jie V. Zhao · 2024 · BMC Medicine
  3. Considerations and Current Trends in the Management of the Geriatric Patient on a Consultation–Liaison Service
    Oliver Glass, Adriana Patricia Hermida, Rachel Hershenberg, Ann C. Schwartz · 2020 · Current Psychiatry Reports
  4. Neuroleptic malignant syndrome: a guide for psychiatrists
    Ovais Wadoo, Sami Ouanes, Mudasir Firdosi · 2020 · BJPsych Advances
  5. Drug–drug interactions involving antipsychotics and antihypertensives
    A Buzea, Lorena Dima, Christoph Ulrich Correll, Peter Manu · 2022 · Expert Opinion on Drug Metabolism & Toxicology
  6. Confounder or Confederate? The Interactions Between Drugs and the Gut Microbiome in Psychiatric and Neurological Diseases
    Lena Michaelis, Lara Berg, Lisa Maier · 2023 · Biological Psychiatry
  7. The Implications of Cytochrome P450 2D6/CYP2D6 Polymorphism in the Therapeutic Response of Atypical Antipsychotics in Adolescents with Psychosis—A Prospective Study
    Adriana Cojocaru, Adina Braha, Roxana Maria Jeleriu, Nicoleta Ioana Andreescu, Maria Puiu, Luminita Ageu, Roxana Folescu, Carmen Lăcrămioara Zamfir, Laura Alexandra Nussbaum · 2024 · Biomedicines
  8. Oral Lubrication, Xerostomia, and Advanced Macromolecular Lubricants for Treatment of Dry Mouth
    William J Austin, Maryam Hdeib, Paige Fraser, Maya Goldchtaub, Elika Shams, Tianyi Han, Pierre-Luc Michaud, Vahid Adibnia · 2024 · Lubricants
  9. The Effects of Antipsychotic Drugs and Non-Pharmacological Therapies on Schizophrenia
    Rateep Nasim, Sadaf Nawaz, Talat Nasim · 2025 · Targets
  10. Trend survey on adverse event profiles of antipsychotic long-acting injections and oral agents using the Japanese adverse drug event report database
    Masakazu Hatano, Hiroyuki Kamei, Akane Shimato, Shigeki Yamada, Nakao Iwata · 2020 · Psychiatry Research
  11. Targeting α6GABAA receptors as a novel therapy for schizophrenia: A proof-of-concept preclinical study using various animal models
    Ming Tatt Lee, Akihiro Mouri, Hisayoshi Kubota, Hsin‐Jung Lee, Man‐Hsin Chang, Chen-Yi Wu, Daniel E. Knutson, Marko D. Mihovilovič, James Minton Cook, Werner Sieghart et al. · 2022 · Biomedicine & Pharmacotherapy
  12. Oral versus long-acting injectable antipsychotics in schizophrenia spectrum disorders: A systematic review of patients’ subjective experiences
    Sofia Francesca Aprile, Alessandro Rodolico, Antonio Di Francesco, Sofia Varrasi, Irene Bighelli, Sabrina Castellano, Maria Salvina Signorelli, Stefan Leucht, Filippo Caraci · 2025 · Psychiatry Research
  13. Effects of a six-month yoga intervention on the immune-inflammatory pathway in antipsychotic-stabilized schizophrenia patients: A randomized controlled trial
    Thrinath Mullapudi, Monojit Debnath, Ramajayam Govindaraj, Praveen Raj, Moinak Banerjee, Shivarama S. Varambally · 2023 · Asian Journal of Psychiatry
  14. Fidelity of Delivery and Contextual Factors Influencing Children’s Level of Engagement: Process Evaluation of the Online Remote Behavioral Intervention for Tics Trial
    Kareem Khan, Chris P. Hollis, Charlotte Lucy Hall, Elizabeth Murray, E Bethan Davies, Per Andrén, David Mataix‐Cols, Tara L Murphy, Cris Glazebrook · 2021 · Journal of Medical Internet Research
  15. Evidence of lithium underuse in bipolar disorder: analysis of lithium and antipsychotic consumption, prediction of future trends, regional disparities and indicators of rational and inappropriate use in Europe
    Lilly Josephine Bindel, Roland Seifert · 2025 · Naunyn-Schmiedeberg s Archives of Pharmacology
  16. Influence of CYP2C19 and CYP2D6 on side effects of aripiprazole and risperidone: A systematic review
    Emma Y De Brabander, Kristian Kleine Schaars, Thérèse van Amelsvoort, Monika Budde, Urs Heilbronner, Allan Hunter Young, Mário F. Juruena, Eduard Vieta, Natalia E. Fares‐Otero, Martien J. Kas et al. · 2024 · Journal of Psychiatric Research
  17. A synergistic effect between family intervention and rTMS improves cognitive and negative symptoms in schizophrenia: A randomized controlled trial
    Xue Li, Xiuxia Yuan, Yulin Kang, Lijuan Pang, Yafei Liu, Qiyue Zhu, Luxian Lv, Xu‐Feng Huang, Xueqin Song · 2020 · Journal of Psychiatric Research
  18. Clozapine induces metformin-resistant prediabetes/diabetes that is associated with poor clinical efficacy in patients with early treatment-resistant schizophrenia
    Chuanjun Zhuo, Yong Ji Xu, Haibo Wang, Chunhua Zhou, Jian Liu, Xiaocui Yu, Hailin Shao, Hongjun Tian, Tao Fang, Qianchen Li et al. · 2021 · Journal of Affective Disorders
  19. Metformin as a potential antidepressant: Mechanisms and therapeutic insights in depression
    Yuan‐Yuan Cheng, Qi Zheng Yao, Yang Miao, Wei Guan · 2025 · Biochemical Pharmacology
  20. Socioeconomic status and access to mental health care: The case of psychiatric medications for children in Ontario Canada
    Janet Currie, Paul A. Kurdyak, Jonathan Zhang · 2023 · Journal of Health Economics
  21. Postoperative Delirium and Neurocognitive Disorders: A Comprehensive Review of Pathophysiology, Risk Factors, and Management Strategies
    Sharayu Paunikar, Vivek Chakole · 2024 · Cureus
  22. Gut bacteria: an etiological agent in human pathological conditions
    Md Minarul Islam, Nasir Uddin Mahbub, Seong‐Tshool Hong, Hea‐Jong Chung · 2024 · Frontiers in Cellular and Infection Microbiology
  23. Sexuality and sexual dysfunctions in older people: a forgotten problem
    Philip Slack, Victor Michael Aziz · 2020 · BJPsych Advances
  24. Management of constipation in patients with schizophrenia—a case study and review of literature
    Ashish Sarangi, Sabiha Armin, Aurelio Vargas, Victoria Chu, Kristen Fain, Jessica E. Nelson · 2021 · Middle East Current Psychiatry
  25. Sexual dysfunctions are associated with major depression, chronic inflammation and anticholinergic consumption in the real-world schizophrenia FACE-SZ national cohort
    Guillaume B. Fond, Ophélia Godin, Marion Dumontaud, Catherine Faget, Franck Schürhoff, Fabrice Sébastien Berna, Bruno Aouizerate, Delphine Capdevielle, Isabelle Chéreau, Thierry d’Amato et al. · 2019 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  26. Pharmacological interventions targeting α-synuclein aggregation triggered REM sleep behavior disorder and early development of Parkinson's disease
    Lida Du, Xiaoli He, Xiaonuo Fan, Xiaoya Wei, Linhao Xu, Tuo Liang, Chunbo Wang, Ya Ke, Wing‐Ho Yung · 2023 · Pharmacology & Therapeutics
  27. Psychiatric Comorbidities and Schizophrenia in Youths With Attention-Deficit/Hyperactivity Disorder
    Soo Min Jeon, Dong Yun Lee, SangHun Cha, Jin‐Won Kwon · 2023 · JAMA Network Open
  28. Usability and Feasibility of the Antipsychotic Medication Decision Aid in a Community Program for First-Episode Psychosis
    Yaara Zisman‐Ilani, Morgan Parker, Elizabeth C. Thomas, John Suarez, Irene M. Hurford, Andrea Bowen, Monica E. Calkins, Patricia E. Deegan, Ilana R. Nossel, Lisa B. Dixon · 2024 · Psychiatric Services
  29. Unlocking the secrets of trace amine-associated receptor 1 agonists: new horizon in neuropsychiatric treatment
    Britto Shajan, Tarun Joseph Bastiampillai, Shane D. Hellyer, Pramod C. Nair · 2024 · Frontiers in Psychiatry
  30. Factors to consider during the implementation of nutrition and physical activity trials for people with psychotic illness into an Australian community setting
    Doreen Mucheru, Samantha Ashby, Mary‐Claire Hanlon, Mark McEvoy, Lesley K. MacDonald‐Wicks · 2020 · BMC Health Services Research
  31. Prescription Pattern and Off-Label Use of Antipsychotics in a Middle Eastern Population
    Kholoud Bastaki, Mohammed El Anbari, Suhaila Ghuloum, Puthen Veettil Jithesh · 2021 · Frontiers in Pharmacology
  32. Early Markers in Resistant Schizophrenia: Effect of the First Antipsychotic Drug
    Georgi Panov · 2022 · Diagnostics
  33. Therapeutic Application of Lithium in Bipolar Disorders: A Brief Review
    Zubair Mahmood Kamal, Siddhartha Dutta, Sayeeda Rahman, Ayukafangha Etando, Emran Hasan, Sayeda Nazmun Nahar, Wan Farizatul Shima Wan Ahmad Fakuradzi, Susmita Sinha, Mainul Haque, Rahnuma Ahmad · 2022 · Cureus
  34. Management of sexual adverse effects induced by atypical antipsychotic medication
    Laura M. Downing, David D. Kim, Ric M. Procyshyn, Philip G. Tibbo · 2019 · Journal of Psychiatry and Neuroscience
  35. Serum autoantibodies against α7-nicotinic receptors in subgroups of patients with bipolar disorder or schizophrenia: clinical features and link with peripheral inflammation
    Estelle Darrau, Elise Jacquemet, Stéphanie Pons, Laurène Schlick, Marios Zouridakis, Ching‐Lien Wu, Jean‐Romain Richard, Caroline Barau, Philippe Le Corvoisier, Robert H. Yolken et al. · 2024 · Translational Psychiatry
  36. The efficacy of Lactobacillus and Bifidobacterium in patients with schizophrenia: a meta-analysis
    Mi Yang, Xingxing Cui, Di Kong, Xincheng Huang, Guocheng Zhao, Xiuying Li, Huachang Zhao, Liju Liu, Fei Yan, Yan Yang et al. · 2024 · European Archives of Psychiatry and Clinical Neuroscience
  37. A multidimensional assessment of adverse events associated with paliperidone palmitate: a real-world pharmacovigilance study using the FAERS and JADER databases
    Siyu Lou, Zhi-Wei Cui, Yingyong Ou, Junyou Chen, Linmei Zhou, Ruizhen Zhao, Chengyu Zhu, Li Wang, Zhu Wu, Fan Zou · 2025 · BMC Psychiatry
  38. Association Between ApoA1 Gene Polymorphisms and Antipsychotic Drug-Induced Dyslipidemia in Schizophrenia
    Lin Fan, Yiwen You, Yao Fan, Chong Shen, Yong Xue · 2021 · Neuropsychiatric Disease and Treatment
  39. The roles of serotonin in cell adhesion and migration, and cytoskeletal remodeling
    Joe Anand Kumar John Jayakumar, Mitradas M. Panicker · 2021 · Cell Adhesion & Migration
  40. Impact of drug-induced Parkinsonism and tardive dyskinesia on health-related quality of life in schizophrenia
    Gurpreet Rekhi, Jenny Tay, Jimmy Lee · 2022 · Journal of Psychopharmacology
  41. Efficacy and safety profiles of mood stabilizers and antipsychotics for bipolar depression: a systematic review
    Cai, Luyao, Chen, Guanjie, Yang, Haichen, Bai, Yuanhan · 2023 · International Clinical Psychopharmacology
  42. The Relationship between Oral Health and Schizophrenia in Advanced Age—A Narrative Review in the Context of the Current Literature
    Sanjana Santhosh Kumar, Raquel Cantillo, Dongxia Ye · 2023 · Journal of Clinical Medicine
  43. IUPHAR review: Moving beyond dopamine-based therapeutic strategies for schizophrenia
    Paula M. Moran, Kiri T. Granger · 2025 · Pharmacological Research
  44. Lithium and Atypical Antipsychotics: The Possible WNT/β Pathway Target in Glaucoma
    Alexandre Vallée, Jean-Noël Vallée, Yves Lecarpentier · 2021 · Biomedicines
  45. The Risk of QTc Prolongation with Antiemetics in the Palliative Care Setting: A Narrative Review
    Elizabeth Marie Gavioli, Nerli Guardado, Farah Haniff, Nouran Deiab, Etty Vider · 2021 · Journal of Pain & Palliative Care Pharmacotherapy
  46. The tetrapartite synapse in neuropsychiatric disorders: Matrix metalloproteinases (MMPs) as promising targets for treatment and rational drug design
    Adriano José Maia Chaves Filho, Melina Mottin, Deniele Bezerra Lós, Carolina Horta Andrade, Danielle S. Macêdo · 2022 · Biochimie
  47. Reviewing the Potential Therapeutic Approaches Targeting the Modulation of Gastrointestinal Microflora in Schizophrenia
    Ilinca-Bianca Nita, Ovidiu‐Dumitru Ilie, Alin Stelian Ciobica, Luminiţa Diana Hrițcu, Irina Dobrin, Bogdan Doroftei, Romeo Dobrin · 2022 · International Journal of Molecular Sciences
  48. Reservoir-type intranasal implants for sustained release of risperidone: A potential alternative for long-term treatment of schizophrenia
    Emilia Utomo, Linlin Li, Jiaqi Gao, Qonita Kurnia Anjani, Camila J. Picco, Natalia Moreno‐Castellanos, Ryan F. Donnelly, Juan Domínguez‐Robles, Eneko Larrañeta · 2024 · Journal of Drug Delivery Science and Technology
  49. Physical activity for adolescents with severe mental illness: a systematic scoping review
    Justine Anthony, Florence‐Emilie Kinnafick, Anthony Papathomas, Kieran C. Breen · 2020 · International Review of Sport and Exercise Psychology
  50. Toxicology of Psychoactive Substances
    Lara Prisco, Aarti Sarwal, Mario Ganau, Francesca Maria Rubulotta · 2021 · Critical Care Clinics
  51. Real-World Adherence and Discontinuation of Oral Antipsychotics and Associated Factors in a National Sample of US Medicare Beneficiaries with Schizophrenia
    Christopher Zacker, Justin T. Puckett, Sachin J. Kamal‐Bahl · 2024 · ClinicoEconomics and Outcomes Research
  52. Psychosocial determinants of healthcare use costs in kidney transplant recipients
    Luigi Zerbinati, Franco Guerzoni, Nicola Napoli, Antonio Preti, Pasquale B. Esposito, Rosangela Caruso, Francesca Bulighin, Alda Storari, Luigi Giuseppe Grassi, Yuri Battaglia · 2023 · Frontiers in Public Health
  53. Challenges associated with treating and preventing antipsychotic-induced constipation: considerations and cautions when prescribing novel interventions
    Tammie Lee Demler, Kelly Krieger · 2020 · International Clinical Psychopharmacology
  54. Prevalence and predictors of laxatives use in clozapine-related constipation: an observational study
    Masaru Nakamura, Takahiko Nagamine · 2021 · International Clinical Psychopharmacology
  55. Atypical antipsychotics: Managing adverse effects
    Brayden Kameg, Claire Champion · 2021 · Perspectives In Psychiatric Care
  56. Possible involvement of apoptosis in the antipsychotics side effects: A mini‐review
    Jana Osacká, Alexander Kiss, Zdeno Pirník · 2022 · Clinical and Experimental Pharmacology and Physiology
  57. Effects of Psychotropic Medication on Somatic Sterol Biosynthesis of Adult Mice
    Marta Balog, Allison C. Anderson, Marija Heffer, Željka Korade, Károly Mirnics · 2022 · Biomolecules
  58. Long-Acting Injectable Antipsychotic Medication Use in Youth: A Systematic Review of the Literature Along with MedWatch Safety Data and Prescriber Attitudes
    Alexander M. Scharko, Rita Sieracki, Sarah J. Mireski · 2024 · Journal of Child and Adolescent Psychopharmacology
  59. Effects of mindfulness-based interventions (MBIs) on psychotic symptoms and psychological outcomes in patients with schizophrenia spectrum disorders: A systematic review and meta-analysis
    Chuntana Reangsing, Sathit Wongsuraprakit, Sasinun Punsuwun, Sarah E. Oerther · 2024 · Psychiatry Research
  60. Agomelatine as adjunctive therapy with SSRIs or SNRIs for major depressive disorder: a multicentre, double-blind, randomized, placebo-controlled trial
    Yumeng Ju, Wenwen Ou, Haoran Chen, Limin Yang, Yan Long, Hui Liang, Zhenman Xi, Mei Hua Huang, Wentao Chen, Guanyi Lv et al. · 2025 · BMC Medicine
  61. Oral Adverse Effects of Antipsychotic Medications: A Case/Noncase Analysis of EudraVigilance Data
    Leire Urien, Unax Lertxundi, Montserrat García, Carmelo Aguirre, Nerea Jauregizar, Teresa Morera‐Herreras · 2025 · Oral Diseases
  62. Pharmaceutical and personal care product residues in indian sewage: A review on its detection, monitoring and treatment strategies
    S. Bivin Ebenezer, Rajan Gandhimathi, P.V. Nidheesh · 2025 · Journal of Water Process Engineering
  63. Effect of Cuscuta epithymum Acquainted with Risperidone on the Improvement of Clinical Symptoms and Cognitive Impairment in Patients with Schizophrenia: A Triple-Blind Randomized Placebo-Controlled Trial
    Maedeh Parvizi, Farbod Fadai, Moahammad Reza Khodaei-Ardakani, Gholamreza Amin, Leila Abdi, Mehdi Noroozi, Iman Ansari · 2019 · Galen Medical Journal
  64. Characteristics of adverse reactions among antipsychotic drugs using the Korean Adverse Event Reporting System database from 2010 to 2019
    Sanghoon Oh, Sun‐ju Byeon, Soo Jie Chung · 2022 · Journal of Psychopharmacology
  65. The relation between second‐generation antipsychotics and laxative use in elderly patients with schizophrenia
    Ching‐Hua Lin, Hsin‐Yi Lin, Ta‐Chun Lin, Hung‐Yu Chan, Jiahn‐Jyh Chen · 2022 · Psychogeriatrics
  66. Implementation of Pharmacist-led Telepsychiatry Services: Challenges and Opportunities in the Midst of COVID-19
    Savera Ikram Arain, Majed Al Shakhori, Shabeer Ali Thorakkattil, Syed Iqbal Mohiuddin, Fuad Al-Ghamdi · 2022 · Journal of Technology in Behavioral Science
  67. The Perspective of Social Workers on Functioning for Individuals With Schizophrenia: A Delphi Study
    Laura Nuño, Georgina Guilera, Phyllis Solomon, Emilio Rojo, Juana Gómez‐Benito, Maite Barrios · 2021 · Journal of the Society for Social Work and Research
  68. The efficacy of low frequency repetitive transcial magnetic stimulation for treating auditory verbal hallucinations in schizophrenia: Insights from functional gradient analyses
    Yuanjun Xie, Chenxi Li, Muzhen Guan, Tian Zhang, Chaozong Ma, Zhongheng Wang, Zhujing Ma, Huaning Wang, Peng Fang · 2024 · Heliyon
  69. Prevalence and associations of fatigue in psychosis: A systematic review and meta-analysis
    Kim Poole-Wright, Aakash Patel, Fiona Gaughran, Robin M. Murray, Trudie Chalder · 2025 · Schizophrenia Research
  70. Exploring gut microbiota profile induced by antipsychotics in schizophrenic patients: insights from an Eastern European pilot study
    Ilinca-Bianca Nita, Irina-Cezara Văcărean-Trandafir, Roxana-Maria Amărandi, Ovidiu‐Dumitru Ilie, Romeo Dobrin, Andreea Cristina Bejenariu, Iuliu-Cristian Ivanov, Bogdan Doroftei · 2025 · BMC Psychiatry
  71. Prophylactic Administration of Diphenhydramine to Reduce Neuroleptic Side Effects in the Acute Care Setting: A Systematic Review and Meta-Analysis
    Akram Mokhtari, Olivia Yip, Judith Alain, Simon Berthelot · 2020 · Journal of Emergency Medicine
  72. Restless Legs Syndrome and the Use of Antipsychotic Medication: An Updated Literature Review
    Wael K Saber, Ahad R Almuallim, Rami M. Algahtani · 2022 · Cureus
  73. Antipsychotic Drug-Mediated Adverse Effects on Rat Testicles May Be Caused by Altered Redox and Hormonal Homeostasis
    Aleksandra Nikolić‐Kokić, Nikola Tatalović, Jelena M. Brkljačić, Milica Mijović, Vojkan Nestorović, Ana Mijušković, Zorana Oreščanin-Dušić, Teodora Vidonja Uzelac, Milan R. Nikolic, Snezana D. Spasić et al. · 2022 · International Journal of Molecular Sciences
  74. Antipsychotics in the maintenance phase for psychotic depression
    Ahmed Al‐Wandi, Mikael Landén, Axel Nordenskjöld · 2023 · Acta Psychiatrica Scandinavica
  75. Cevimeline co-treatment attenuates olanzapine-induced metabolic disorders via modulating hepatic M3 muscarinic receptor: AMPKα signalling pathway in female rats
    Mei Han, Jiamei Lian, Yueqing Su, Chao Deng · 2021 · Journal of Psychopharmacology
  76. Effects of cannabidiol on vacuous chewing movements, plasma glucose and oxidative stress indices in rats administered high dose risperidone
    Jaiyeola Abiola Kajero, Soraya Seedat, JUDE UZOMA OHAERI, Abidemi James Akindele, Oluwagbemiga Olanrewaju Aina · 2022 · Scientific Reports
  77. Development of a specific fragmentation pattern-based quadrupole-Orbitrap™ mass spectrometry method to screen drugs in illicit products
    Ji Hyun Lee, Han Na Park, Nam Sook Kim, Seongsoo Park, Yong-Moon Lee, Hoil Kang · 2019 · Science & Justice
  78. Implications of Antipsychotic Use
    Sattaria S. Dilks, Rose Mary Xavier, Crystal Marie Kelly, Jessica A. Johnson · 2019 · Nursing Clinics of North America
  79. Schizophrenia and Related Psychoses
    2021 · Wiley eBooks
  80. Metabolic adverse effects of antipsychotics: the state of the problem and management options
    Балашова Анастасия Владимировна, Мамлеева Диана Валерьевна, Lubov V. Machekhina, Е. N. Dudinskaya · 2023 · Obesity and metabolism
  81. The neglected association between schizophrenia and bone fragility: a systematic review and meta-analyses
    Behnaz Azimi Manavi, Kayla B. Corney, Mohammadreza Mohebbi, Shae E. Quirk, Amanda L. Stuart, Julie Anne Pasco, Jason M. Hodge, Michael Berk, Lana J. Williams · 2024 · Translational Psychiatry
  82. Metabolic complications of psychotropic medications in psychiatric disorders: Emerging role of de novo lipogenesis and therapeutic consideration
    Mohammad M. Khan, Zaw Ali Khan, Mohsin Ali Khan · 2024 · World Journal of Psychiatry
  83. Constipation‐associated factors in outpatients with schizophrenia: A multicenter questionnaire survey
    Taro Tazaki, Hiroki Yamada, Ryotaro Sato, Hiroki Ishii, Shutaro Sugita, Haruka Yanagihara, Dan Nakamura, Osamu Takashio, Atsuko Inamoto, Akira Iwanami · 2024 · Neuropsychopharmacology Reports
  84. Epigallocatechin-3-gallate conjugated with selenium nanoparticles prevents neurological complications in rats exhibiting schizophrenia-like behaviors
    Hadeer M. Gamal El-Deen, Amina E. Essawy, Nema A. Mohammed, Mohamed Saleh Abdelfattah, Ayah Samir Fathalla, Manal F. El‐Khadragy, Ahmed E. Abdel Moniem · 2025 · Frontiers in Pharmacology
  85. Neurological Adverse Effects of Antipsychotic Medication in Children and Young People
    Frank Besag, Michael J. Vasey, Chris P. Hollis, David M. Taylor · 2026 · Pediatric Drugs
  86. Adaptive changes to antipsychotics: How to avoid the consequences
    Ahmad Sleem · 2022 · Current Psychiatry
  87. Polystyrene electrospun nanofibers as effective sorbents for the removal of atypical antipsychotics: Kinetic and thermodynamic studies
    Liju Fan, Zefang Yu, Xin Wei, Zhanjun Dong, Jing An · 2022 · Arabian Journal of Chemistry
  88. Relationship between clozapine exposure and the onset of appendicitis in schizophrenia patients: a retrospective cohort study
    Yuta Kawakita, Masahiro Takeshima, Tomonari Komatsu, Aya Imanishi, Dai Fujiwara, Yu Itoh, Kazuo Mishima · 2022 · BMC Psychiatry
  89. Schizophrenia Spectrum and Other Psychotic Disorders
    Alaina V. Burns, Stephen R. Marder · 2023 · Springer eBooks
  90. Relapse in patients with schizophrenia and amisulpride-induced hyperprolactinemia or olanzapine-induced metabolic disturbance after switching to other antipsychotics
    Jingda Cai, Li Li, Tiannan Shao, Mengxi Sun, Weiyan Wang, Peng Xie, Xiaoyi Wang, Ye Yang, Yujun Long, Dongyu Kang et al. · 2023 · Psychiatry Research
  91. Pharmacogenomics-assisted treatment versus standard of care in schizophrenia: a systematic review and meta-analysis
    Saibal Das, Manoj Kalita, Manabendra Makhal, Devaraja Munikrishnappa, Bhavani Shankara Bagepally, Jerin Jose Cherian, Rajesh Aadityan, Mounamukhar Bhattacharjee, Sarnendu Mondal, Sreyashi Sen et al. · 2024 · BMC Psychiatry
  92. Clozapine Induces Agranulocytosis via Inflammatory and Hematopoietic Cytokine Induction of the JAK–STAT Signaling Pathway: Evidence From Network Pharmacology and Molecular Docking
    Ying Zhang, Ranli Li, Ximing Chen, Yachen Li, Qiuyu Zhang, Lei Yang, Lina Wang, Yun Sun, Fuqiang Mao, Chuanjun Zhuo · 2025 · CNS Neuroscience & Therapeutics
  93. IUPHAR Review: Alpha6-containing GABAA receptors – Novel targets for the treatment of schizophrenia
    Lih‐Chu Chiou, Werner Sieghart · 2025 · Pharmacological Research
  94. Genes of the Glutamatergic System and Tardive Dyskinesia in Patients with Schizophrenia
    Olga Y. Fedorenko, Diana Z. Paderina, Elena G. Kornetova, Полтавская Евгения Григорьевна, Ivan V. Pozhidaev, Гончарова Анастасия Александровна, Maxim B. Freidin, А. В. Бочарова, Nikolay A. Bokhan, ANTON J. M. LOONEN et al. · 2022 · Diagnostics
  95. Role of natural products in alleviation of Huntington's disease: An overview
    Mukta Gupta, Sanjana Sanjana, Naresh Singh, Balbir Singh, Perwez Alam · 2022 · South African Journal of Botany
  96. Genetic Biomarkers of Antipsychotic-Induced Prolongation of the QT Interval in Patients with Schizophrenia
    E. E. Vaiman, Natalia Alekseevna Shnayder, N. M. Zhuravlev, Марина Михайловна Петрова, Azat R. Asadullin, Mustafa Al-Zamil, Natalia P. Garganeeva, German Alexandrovich Shipulin, Paul D. Cumming, Regina Faritovna Nasyrova · 2022 · International Journal of Molecular Sciences
  97. Exhaustive in silico design and screening of novel antipsychotic compounds with improved pharmacodynamics and blood-brain barrier permeation properties
    Radu Tamaian, Yuri B. Porozov, Sergey Shityakov · 2023 · Journal of Biomolecular Structure and Dynamics
  98. Antipsychotic-induced tardive dyskinesia as a serious adverse effect in the psychopharmacotherapy of schizophrenia
    E. E. Vaiman, Natalia Alekseevna Shnayder, Н. Г. Незнанов, Regina Faritovna Nasyrova · 2019 · Neurology neuropsychiatry Psychosomatics
  99. Antipsychotic Drug Utilization and Adverse Drug Reaction Profiling in Patients With Schizophrenia at a Tertiary Care Hospital in Western India
    Raakhi Tripathi, Snehalata Vijayanand Gajbhiye, Sharmila Vinayak Jalgaonkar, Nishtha Khatri, Mohsin Sayyed, Shubhangi Parkar · 2022 · Cureus
  100. Vers une meilleure compréhension de la fatigue dans la schizophrénie
    Emmanuel Mulin, Alix Augustin, Mathieu Gruet · 2022 · L Encéphale